BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19077664)

  • 21. Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder.
    Cutler JA; Rush AJ; McMahon FJ; Laje G
    J Psychopharmacol; 2012 Mar; 26(3):360-7. PubMed ID: 22282879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.
    Qesseveur G; Petit AC; Nguyen HT; Dahan L; Colle R; Rotenberg S; Seif I; Robert P; David D; Guilloux JP; Gardier AM; Verstuyft C; Becquemont L; Corruble E; Guiard BP
    Neuropharmacology; 2016 Jun; 105():142-153. PubMed ID: 26764241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial.
    Brunoni AR; Carracedo A; Amigo OM; Pellicer AL; Talib L; Carvalho AF; Lotufo PA; Benseñor IM; Gattaz W; Cappi C
    Braz J Psychiatry; 2020 Apr; 42(2):128-135. PubMed ID: 31721892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Common selective serotonin reuptake inhibitor side effects in older adults associated with genetic polymorphisms in the serotonin transporter and receptors: data from a randomized controlled trial.
    Garfield LD; Dixon D; Nowotny P; Lotrich FE; Pollock BG; Kristjansson SD; Doré PM; Lenze EJ
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):971-9. PubMed ID: 24021217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population.
    Ham BJ; Lee BC; Paik JW; Kang RH; Choi MJ; Choi IG; Lee MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):104-7. PubMed ID: 16979275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study.
    Perlis RH; Moorjani P; Fagerness J; Purcell S; Trivedi MH; Fava M; Rush AJ; Smoller JW
    Neuropsychopharmacology; 2008 Nov; 33(12):2810-9. PubMed ID: 18288090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of serotonin transporter (SLC6A4) and receptor (5HTR1A, 5HTR2A) polymorphisms with response to treatment with escitalopram in patients with major depressive disorder: A preliminary study.
    Basu A; Chadda RK; Sood M; Kaur H; Kukreti R
    Indian J Med Res; 2015 Jul; 142(1):40-5. PubMed ID: 26261165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressant response to chronic citalopram treatment in eight inbred mouse strains.
    Jiao J; Nitzke AM; Doukas DG; Seiglie MP; Dulawa SC
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):509-20. PubMed ID: 21181117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetic Study of Serotonin Transporter and 5HT2A Genotypes in Autism.
    Najjar F; Owley T; Mosconi MW; Jacob S; Hur K; Guter SJ; Sweeney JA; Gibbons RD; Cook EH; Bishop JR
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):467-74. PubMed ID: 26262902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk-taking behavior in a gambling task associated with variations in the tryptophan hydroxylase 2 gene: relevance to psychiatric disorders.
    Juhasz G; Downey D; Hinvest N; Thomas E; Chase D; Toth ZG; Lloyd-Williams K; Mekli K; Platt H; Payton A; Bagdy G; Elliott R; Deakin JF; Anderson IM
    Neuropsychopharmacology; 2010 Apr; 35(5):1109-19. PubMed ID: 20043001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetics of citalopram-related side effects in children with depression and/or anxiety disorders.
    Amitai M; Kronenberg S; Carmel M; Michaelovsky E; Frisch A; Brent D; Apter A; Chen A; Weizman A; Fennig S
    J Neural Transm (Vienna); 2016 Nov; 123(11):1347-1354. PubMed ID: 27324805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex.
    Smith RM; Papp AC; Webb A; Ruble CL; Munsie LM; Nisenbaum LK; Kleinman JE; Lipska BK; Sadee W
    Biol Psychiatry; 2013 Mar; 73(6):546-54. PubMed ID: 23158458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacogenetics of the selective serotonin reuptake inhibitors.
    Brøsen K
    Clin Investig; 1993 Dec; 71(12):1002-9. PubMed ID: 8124052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor.
    Pälvimäki EP; Roth BL; Majasuo H; Laakso A; Kuoppamäki M; Syvälahti E; Hietala J
    Psychopharmacology (Berl); 1996 Aug; 126(3):234-40. PubMed ID: 8876023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of citalopram on serotonin and CRF systems in the midbrain of primates with differences in stress sensitivity.
    Bethea CL; Lima FB; Centeno ML; Weissheimer KV; Senashova O; Reddy AP; Cameron JL
    J Chem Neuroanat; 2011 Jul; 41(4):200-18. PubMed ID: 21683135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucocorticoid receptor antagonism augments fluoxetine-induced downregulation of the 5-HT transporter.
    Johnson DA; Ingram CD; Grant EJ; Craighead M; Gartside SE
    Neuropsychopharmacology; 2009 Jan; 34(2):399-409. PubMed ID: 18496518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective serotonin reuptake inhibitors potentiate 8-OH-DPAT-induced stimulus control in the pigeon.
    Wolff MC; Leander JD
    Eur J Pharmacol; 1998 Mar; 345(1):35-9. PubMed ID: 9593591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The MAOA, COMT, MTHFR and ESR1 gene polymorphisms are associated with the risk of depression in menopausal women.
    Różycka A; Słopień R; Słopień A; Dorszewska J; Seremak-Mrozikiewicz A; Lianeri M; Maciukiewicz M; Warenik-Szymankiewicz A; Grzelak T; Kurzawińska G; Drews K; Klejewski A; Jagodziński PP
    Maturitas; 2016 Feb; 84():42-54. PubMed ID: 26620113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample.
    Peters EJ; Slager SL; Kraft JB; Jenkins GD; Reinalda MS; McGrath PJ; Hamilton SP
    PLoS One; 2008 Apr; 3(4):e1872. PubMed ID: 18382661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.